CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $137,937 | -98.9% | 3,590 | -99.3% | 0.00% | -100.0% |
| Q1 2023 | $12,258,388 | +52.5% | 529,520 | +72.6% | 0.00% | 0.0% |
| Q4 2022 | $8,038,422 | +24.2% | 306,810 | -6.8% | 0.00% | 0.0% |
| Q3 2022 | $6,473,000 | +4.3% | 329,239 | -7.2% | 0.00% | 0.0% |
| Q2 2022 | $6,206,000 | -33.4% | 354,834 | -37.7% | 0.00% | 0.0% |
| Q1 2022 | $9,312,000 | -43.8% | 569,173 | -43.9% | 0.00% | 0.0% |
| Q4 2021 | $16,561,000 | +27.8% | 1,015,381 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,954,000 | +17.8% | 1,015,241 | +30.4% | 0.00% | 0.0% |
| Q2 2021 | $10,993,000 | -18.3% | 778,522 | -10.1% | 0.00% | 0.0% |
| Q1 2021 | $13,455,000 | -2.0% | 865,822 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,732,000 | – | 865,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |